ARCHIVES

In Brief: ACS Asks Removal Of Dollar Authorization Levels; FDA May Overrule Advisors On Estramustine

This article is from The Cancer Letter archive.

Vol. 05 No. 47 | November 23, 1979

Download PDF Visit The Full Archive

Related Articles

Advice Rolls In As Upton Proceeds With NCI Reorganization, Stands Firm On His Program

March 17, 1978

Researchers Call For New Approach To Peripheral Neuropathy Testing

February 24, 2012

In Brief: Two New Section Chiefs Named In NCI Research Contracts Branch; S. 988 Markup Set For April 25

April 18, 1980

In Brief: white House Names Phillip Sharp To NCAB; Shine Re-appointed As IOM President

September 27, 1996

About Need For Cancer Research Funding

February 3, 1995

Longterm Followup Finds Taxotere Improves Survival

January 25, 2008